Jessica Wenthe
- Oncology top 5%
- CAR-T cell therapy research 19
- Cancer Immunotherapy and Biomarkers 2
- Immunology top 10%
- Immunotherapy and Immune Responses 6
- Genetics top 10%
- Virus-based gene therapy research 21
- Biotechnology top 10%
- Cancer Research and Treatments 12
-
- Viral Infectious Diseases and Gene Expression in Insects 3
- RNA Interference and Gene Delivery 2
- Extracellular vesicles in disease 1
- Co-authors
- Angelica LoskogEmma ErikssonGustav UllenhagSandra IrenaeusTanja LövgrenRamón AlemanyKristina WikströmGunilla Enblad
- Cited by
- OncologyImmunologyGenetics
- Journals
- Cancer Research (6 papers)Journal of Translational Medicine (3 papers)Molecular Therapy (2 papers)
- Partner nations
- SwedenUnited StatesSpain
In The Last Decade
Jessica Wenthe
22 papers receiving 787 citations
Peers
Comparison fields: 5 of 48
- Oncology 611
- Immunology 315
- Genetics 312
- Biotechnology 82
- Molecular Biology 225
Countries citing papers authored by Jessica Wenthe
This map shows the geographic impact of Jessica Wenthe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jessica Wenthe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jessica Wenthe more than expected).
Fields of papers citing papers by Jessica Wenthe
This network shows the impact of papers produced by Jessica Wenthe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jessica Wenthe. The network helps show where Jessica Wenthe may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jessica Wenthe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2024 | 36 | |
| 3 | 2023 | 6 | |
| 4 | 2023 | 0 | |
| 5 | 2023 | 0 | |
| 6 | 2022 | 11 | |
| 7 | 2022 | 1 | |
| 8 | 2021 | 40 | |
| 9 | 2021 | 34 | |
| 10 | 2020 | 7 | |
| 11 | 2020 | 39 | |
| 12 | 2020 | 10 | |
| 13 | 2020 | 1 | |
| 14 | 2019 | 42 | |
| 15 | 2018 | 207 | |
| 16 | 2017 | 116 | |
| 17 | 2017 | 37 | |
| 18 | 2017 | 1 | |
| 19 | 2016 | 176 | |
| 20 | 2016 | 3 |
About Jessica Wenthe
Jessica Wenthe is a scholar working on Biotechnology, Oncology and Genetics, having authored 24 papers that have together received 799 indexed citations. Recurring topics across this work include Virus-based gene therapy research (21 papers), CAR-T cell therapy research (19 papers), Cancer Research and Treatments (12 papers), Immunotherapy and Immune Responses (6 papers), Viral Infectious Diseases and Gene Expression in Insects (3 papers), RNA Interference and Gene Delivery (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Extracellular vesicles in disease (1 paper). The work is most often cited by research in Oncology (611 citations), Immunology (315 citations) and Genetics (312 citations). Jessica Wenthe has collaborated with scholars based in Sweden, United States and Spain. Frequent co-authors include Angelica Loskog, Emma Eriksson, Gustav Ullenhag, Sandra Irenaeus, Tanja Lövgren, Ramón Alemany, Kristina Wikström, Gunilla Enblad, Malcolm K. Brenner and Barbara Savoldo. Their work appears in journals such as Cancer Research, Journal of Translational Medicine, Molecular Therapy, Clinical Cancer Research and Molecular Therapy — Oncolytics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.